Camber Capital Management LLC, 10% Owner at Protalix BioTherapeutics, Inc. (PLX), bought 4,000,423 shares at $1.00 ($4.0M) on 2015-10-19, disclosed to the SEC on 2015-10-20.
Open-market purchase of $4.0M PLX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.00 | 4,000,000 | $4.0M | 100.0% |
| 2 | $1.03 | 423 | $436 | 0.0% |
| Total | $1.00 avg | 4,000,423 | $4.0M | 100% |
| Filing → |
| CSII | BUY | 2016-02-25 | $1.9M | — | Filing → |
| SQNM | BUY | 2016-01-04 | $1.7M | — | Filing → |
| SQNM | BUY | 2015-12-17 | $610K | — | Filing → |